Recurrent asymptomatic bradycardia episodes after cisplatin infusion

被引：16

作者：

Altundag, Ö ^{[1
]}

Çelik, I ^{[1
]}

Kars, A ^{[1
]}

机构：

[1] Hacettepe Univ, Inst Oncol, Dept Med Oncol, TR-06100 Sihhiye Ankara, Turkey

来源：

ANNALS OF PHARMACOTHERAPY | 2001年 / 35卷 / 05期

关键词：

D O I：

10.1345/aph.10180

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：641 / 642

页数：2

共 12 条

[1] RENAL AND ELECTROLYTE DISTURBANCES ASSOCIATED WITH CISPLATIN [J].

BLACHLEY, JD ;

HILL, JB .

ANNALS OF INTERNAL MEDICINE, 1981, 95 (05) :628-632

[2]

CONNOBIO L, 1986, TUMORI, V72, P201

[3] SUPRAVENTRICULAR TACHYCARDIA - A PROBABLE COMPLICATION OF PLATINUM TREATMENT [J].

HASHIMI, LA ;

KHALYL, MF ;

SALEM, PA .

ONCOLOGY, 1984, 41 (03) :174-175

[4]

Hochster Howard, 1995, Current Opinion in Oncology, V7, P304, DOI 10.1097/00001622-199507000-00002

[5] DRUGS 5 YEARS LATER - CISPLATIN [J].

LOEHRER, PJ ;

EINHORN, LH .

ANNALS OF INTERNAL MEDICINE, 1984, 100 (05) :704-713

[6] CARDIORESPIRATORY DECOMPENSATION FOLLOWING METHYLPREDNISOLONE ADMINISTRATION [J].

LUCAS, KG ;

HOWRIE, DL ;

PHEBUS, CK .

PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1993, 10 (03) :249-255

[7] CISPLATIN-INDUCED ATRIAL-FIBRILLATION [J].

MENARD, O ;

MARTINET, Y ;

LAMY, P .

JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (01) :192-193

[8] A METHOD FOR ESTIMATING THE PROBABILITY OF ADVERSE DRUG-REACTIONS [J].

NARANJO, CA ;

BUSTO, U ;

SELLERS, EM ;

SANDOR, P ;

RUIZ, I ;

ROBERTS, EA ;

JANECEK, E ;

DOMECQ, C ;

GREENBLATT, DJ .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (02) :239-245

[9]

Petrella V, 1989, Minerva Med, V80, P305

[10]

SARTORI S, 1993, ONCOLOGY, V53, P230

← 1 2 →